The multitasking molecular chaperone Hsp60
Structure, function, and impact on health and disease
- 1st Edition - October 19, 2024
- Editors: Francesco Cappello, Everly Conway de Macario, Alberto JL Macario
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 3 9 9 6 - 0
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 3 9 9 7 - 7
The Multitasking Molecular Chaperone Hsp60: Structure, Function, and Impact on Health and Disease provides an overview of this key component of the Chaperone System (CS). The bo… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Multitasking Molecular Chaperone Hsp60: Structure, Function, and Impact on Health and Disease provides an overview of this key component of the Chaperone System (CS). The book covers various areas of medicine in which Hsp60 chaperonopathies have been identified. Various chapters discuss the Hsp60 structure, localization, functions, and participation in disease mechanisms both genetic and acquired, focusing on humans but also presenting data obtained from pro- and eukaryotic experimental models. The main goal is to provide information accessible to all healthcare professionals in a way that can be understood by nonspecialists and that would stimulate clinical and pathological detection of Hsp60 chaperonopathies.
Molecular mechanisms are briefly described with the purpose of illuminating roads toward accurate diagnosis, treatment, and patient monitoring. Consequently, the possibility of developing/applying chaperonotherapy centered on Hsp60, as a therapeutic tool or target, is analyzed in many sections of this book, across a variety of medical specialties. Over the last several years, the importance of the CS as a physiological system has been brought to prominence and its roles in health and disease made clear. The molecular chaperones, including Hsp60, are the key components of the CS that are typically cytoprotective, but they can also be etiopathogenic factors, causing diseases named chaperonopathies.
Molecular mechanisms are briefly described with the purpose of illuminating roads toward accurate diagnosis, treatment, and patient monitoring. Consequently, the possibility of developing/applying chaperonotherapy centered on Hsp60, as a therapeutic tool or target, is analyzed in many sections of this book, across a variety of medical specialties. Over the last several years, the importance of the CS as a physiological system has been brought to prominence and its roles in health and disease made clear. The molecular chaperones, including Hsp60, are the key components of the CS that are typically cytoprotective, but they can also be etiopathogenic factors, causing diseases named chaperonopathies.
- Discusses strategies for diagnosis, patient monitoring, and treatment of disorders in which Hsp60 plays a role and can be used as biomarker and therapeutic target or agent
- Explains the fundamental biophysics, genetics, physiology, and pathogenicity of Hsp60
- Explores the mechanisms involving Hsp60 abnormalities causing disease, including carcinogenesis, inflammation, autoimmunity, and neurodegenerative disorders
Researchers in molecular biology, biochemistry, biophysics, biomedicine, pharmacology and related life sciences, Students in biochemistry, molecular biology, biophysics, pharmacology, and related areas
- Title of Book
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Preface
- Chapter One. The chaperone system and its diseases: Introductory overview focusing on Hsp60
- 1 The chaperone system
- 2 The chaperonopathies
- 3 Hsp60
- 4 Components and properties of the CS
- 5 Mapping the CS components in tissues and cells
- 6 The chapters
- Chapter Two. Physical and biochemical properties of the molecular chaperone Hsp60
- 1 Hsp60, a member of the chaperone system
- 2 Oligomeric structure and allosteric states
- 3 Structural diversity of Hsp60 with implications for pathology
- 4 Further comments on Hsp60 functional diversity
- 5 Hsp60 post-translational modifications
- 5.1 Acetylation
- 5.2 Nitration and S-nitrosylation
- 5.3 Phosphorylation
- Chapter Three. The spectrum of human Hsp60 genetic variants and associated chaperonopathies
- 1 Introduction. Human Hsp60 chaperonin: origin, and physiological and physiopathological roles
- 2 Chaperonopathies and Hsp60-associated chaperonopathies
- 3 Hsp60 genetic chaperonopathies affecting the nervous system
- 3.1 Diseases description and clinical presentation
- 4 In vitro, in vivo, and in silico studies to elucidate molecular mechanisms in Hsp60 chaperonopathies
- 5 Hsp60 genetic chaperonopathies affecting the cardiovascular system
- 5.1 Disease description and clinical presentation
- 5.2 In vitro and in vivo studies to elucidate molecular mechanisms in Hsp60 chaperonopathies affecting the cardiovascular system
- 6 HSPD1 gene single-nucleotide variations and their contribution to diseases associated with variants of other genes
- 7 Discussion and conclusion
- Chapter Four. Hsp60 in inflammation and autoimmunity
- 1 Introduction
- 2 Molecular mimicry: A link between infection and autoimmunity and chronic inflammation
- 3 Autoimmune and chronic inflammatory diseases as chaperonopathies by mistake or collaborationism: The role of Hsp60
- 3.1 Hsp60 in autoimmune diseases
- 3.2 Hsp60 in chronic inflammatory diseases
- 4 Hsp60 and virus-induced diseases
- 5 Conclusion
- Chapter Five. Hsp60 and carcinogenesis
- 1 Introduction
- 1.1 Protein folding and protein quality control
- 1.2 Stress response
- 1.3 Antiapoptotic effects
- 1.4 Immune system modulation
- 1.5 Clinical implications
- 2 Breast cancer
- 3 Cervical cancer
- 4 Colorectal cancer
- 5 Gastric cancer
- 6 Head and neck squamous cell carcinoma
- 7 Hepatocellular carcinoma
- 8 Kidney carcinoma
- 9 Lung cancer
- 10 Prostate cancer and precancerous lesions
- 11 Thyroid cancer
- 12 Conclusions
- 12.1 Multifaceted roles unveiled
- 12.2 Prognostic beacon amid complexity
- 12.3 Anticancer strategies redefined
- 12.4 Harnessing potential for progress
- Chapter Six. Hsp60 involvement in articular cartilage tissue homeostasis and pathogenesis
- 1 Introduction
- 2 Histomorphological features of articular cartilage
- 3 The chaperone system in arthritis
- 4 Hsp60 in autoimmune and inflammatory rheumatic arthritis
- 5 Therapeutic implications of Hsp60 in autoimmune and inflammatory rheumatic arthritis
- 6 Hsp60 in osteoarthritis
- 7 Hsp60 in chondrosarcoma and osteosarcoma
- 8 Conclusions and future perspectives
- Chapter Seven. Hsp60 and skeletal muscle diseases
- 1 Introduction
- 2 Adaptations of skeletal muscle fibers
- 3 Distribution and levels of Hsp60 in skeletal muscle tissues
- 4 Hsp60 expression and its implications in skeletal muscle pathologies
- 5 Recent work on Hsp60 in skeletal muscle pathology
- 6 Conclusions and perspectives
- Chapter Eight. Hsp60 and cardiovascular diseases
- 1 Introduction
- 2 Heart
- 3 Heart failure
- 4 Vascular Hsp60
- 5 Atherosclerosis
- 6 Conclusions
- Chapter Nine. Hsp60 in physiology and pathophysiology of the respiratory system
- 1 Introduction
- 1.1 Hsp60 in the RS from embryo to adult in health and disease
- 2 Chronic obstructive pulmonary disease
- 3 Asthma
- 4 Lung cancer
- 5 Pulmonary parenchyma infections and SARS-CoV-2
- 6 Conclusion
- Chapter Ten. Hsp60 and diseases of the digestive system
- 1 Introduction
- 2 The gastrointestinal tract
- 3 Inflammatory bowel diseases
- 4 Bowel cancer
- 5 Celiac disease
- 6 Coda
- Chapter Eleven. The chaperone system and the pathophysiology of the urogenital apparatus: Hsp60 roles
- 1 Introduction
- 2 The multifaceted role of Hsp60 in renal health
- 2.1 Pioneering studies on Hsp60/early research on Hsp60 in the kidney
- 2.2 Recent research on the expression of Hsp60 in the kidney
- 3 Female reproductive system
- 3.1 Ovary and oviduct
- 3.2 Uterus
- 4 Male reproductive system
- 4.1 Male infertility and spermatogenesis: The latest research on Hsp60
- 4.2 Prostate
- 5 The role of chlamydial Hsp60 in infertility and diagnostic advancements
- Chapter Twelve. Hsp60 and nervous system development and diseases
- 1 Introduction
- 2 Hsp60 and neurodegenerative disorders
- 3 Alzheimer's disease
- 4 Parkinson's disease
- 5 Huntington's disease
- 6 Creutzfeldt–Jakob disease
- 7 Amyotrophic lateral sclerosis
- 8 Multiple sclerosis
- 9 Hsp60 and tumors of the NS
- Chapter Thirteen. Hsp60 and pathophysiology of the neuroendocrine system
- 1 Introduction
- 2 NES overview
- 3 Heat shock proteins and the NES
- 4 Hsp60 in the hypothalamus, and pituitary and adrenal glands under thermal stress
- 5 Hsp60 in neuropsychiatric disorders
- 6 Hsp60 in adrenal dysfunction and tumors
- 7 Hsp60 in diabetes mellitus
- 8 Hsp60 in thyroid diseases including autoimmune pathologies
- 9 Conclusion
- Chapter Fourteen. Hsp60 and artificial intelligence
- 1 Introduction
- 2 Recent discoveries and tools with impact in medical sciences and healthcare
- 3 AI in protein science, chaperonology, and healthcare
- Appendix I: Supplementary material for Chapter 3
- Appendix II: Late-breaking news
- Chapter 1: The chaperone system and its diseases: Introductory overview focusing on Hsp60
- Chapter 2: Physical and biochemical properties of the molecular chaperone Hsp60
- Chapter 3: The spectrum of human Hsp60 genetic variants and associated chaperonopathies
- Chapter 4: Hsp60 in inflammation and autoimmunity
- Chapter 5: Hsp60 and carcinogenesis
- Chapter 6: Hsp60 involvement in cartilage tissue homeostasis and pathogenesis
- Chapter 7: Hsp60 and skeletal muscle diseases
- Chapter 8: Hsp60 and cardiovascular diseases
- Chapter 9: Hsp60 in physiology and pathophysiology of the respiratory system
- Chapter 10: Hsp60 and diseases of the digestive system
- Chapter 11: The chaperone system and the pathophysiology of the urogenital apparatus: Hsp60 roles
- Chapter 12: Hsp60 and nervous system development and diseases
- Chapter 13: Hsp60 and pathophysiology of the neuroendocrine system
- Chapter 14: Hsp60 and artificial intelligence
- Index
- No. of pages: 400
- Language: English
- Edition: 1
- Published: October 19, 2024
- Imprint: Academic Press
- Paperback ISBN: 9780443239960
- eBook ISBN: 9780443239977
FC
Francesco Cappello
Francesco Cappello is Full Professor of Anatomy and Histology at the University of Palermo, Palermo, Italy. He is also President of the Italian Society of Experimental Biology, Life member of the Cell Stress Society International and former Senior Editor of Cell Stress and Chaperones. He has been nominated “Adjunct Professor” at the Temple University of Philadelphia (PA, USA) and at the University of Texas Medical Branch of Galveston (TX, USA). He has authored more than 300 scientific papers.
Affiliations and expertise
Professor, Anatomy and Histology, University of Palermo, Palermo, ItalyEC
Everly Conway de Macario
Everly Conway de Macario is Adjunct Professor at the School of Medicine, University of Maryland at Baltimore, Baltimore, MD, USA. She has written 320 articles, authored 1 book and edited 8 books. Dr. Conway de Macario’s research interests include the development of the concept of sick chaperone or chaperonopathy as a factor contributing to the ageing process and disease, elucidation of the entire set of hsp70 genes in the human genome, and characterization of the whole complement of cct-Hsp60 genes in the human genome.
Affiliations and expertise
Adjunct Professor, School of Medicine, University of Maryland, Baltimore, Maryland, USAAJ
Alberto JL Macario
Alberto JL Macario is Adjunct Professor at the School of Medicine, University of Maryland at Baltimore, Baltimore, MD, USA. He has authored 380 articles, is the author of 1 book, and editor of 7 books. Dr. Macario is also Group Leader at the Euro-Mediterranean Institute of Science and Technology, Palermo, Italy. His current interests are chaperonopathies pertaining to Hsp60, Hsp10, and CCT genes/proteins.
Affiliations and expertise
Adjunct Professor, School of Medicine, University of Maryland, Baltimore, Maryland, USARead The multitasking molecular chaperone Hsp60 on ScienceDirect